These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9345422)

  • 1. Emerging treatments in multiple sclerosis: azathioprine and mofetil.
    Confavreux C; Moreau T
    Mult Scler; 1996 Jul; 1(6):379-84. PubMed ID: 9345422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycophenolate mofetil, azathioprine and methotrexate usage in paediatric anti-NMDAR encephalitis: A systematic literature review.
    Nosadini M; Mohammad SS; Toldo I; Sartori S; Dale RC
    Eur J Paediatr Neurol; 2019 Jan; 23(1):7-18. PubMed ID: 30318435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is mycophenolate mofetil an effective alternative in azathioprine-intolerant patients with chronic active Crohn's disease?
    Miehsler W; Reinisch W; Moser G; Gangl A; Vogelsang H
    Am J Gastroenterol; 2001 Mar; 96(3):782-7. PubMed ID: 11280551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycophenolate mofetil versus azathioprine in patients with chronic active ulcerative colitis: a 12-month pilot study.
    Orth T; Peters M; Schlaak JF; Krummenauer F; Wanitschke R; Mayet WJ; Galle PR; Neurath MF
    Am J Gastroenterol; 2000 May; 95(5):1201-7. PubMed ID: 10811328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
    Transplantation; 1996 Apr; 61(7):1029-37. PubMed ID: 8623181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safe conversion of mycophenolate mofetil to azathioprine in kidney transplant recipients with sirolimus-based immunosuppression.
    El-Agroudy AE; El-Dahshan KF; Wafa EW; Sheashaa HA; Gad ZA; Ismail AM; Shokeir AA; Ghoneim MA
    Nephrology (Carlton); 2009 Apr; 14(2):255-61. PubMed ID: 19017277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Transplantation; 1998 Jan; 65(2):235-41. PubMed ID: 9458021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate mofetil (MMF) versus azathioprine (AZA) in pancreas transplantation: a single-center experience.
    Rigotti P; Cadrobbi R; Baldan N; Sarzo G; Parise P; Furian L; Marchini F; Ancona E
    Clin Nephrol; 2000 Apr; 53(4):suppl 52-4. PubMed ID: 10809437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New immunosuppressive treatment in kidney transplantation.
    Di Landro D; Sarzo G; Marchini F
    Clin Nephrol; 2000 Apr; 53(4):suppl 23-32. PubMed ID: 10809431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance immunosuppression with mycophenolate mofetil: long-term efficacy and safety after heart transplantation.
    Dandel M; Jasaityte R; Lehmkuhl H; Knosalla C; Hetzer R
    Transplant Proc; 2009; 41(6):2585-8. PubMed ID: 19715979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of mycophenolate mofetil versus azathioprine in renal transplantation: a systematic review.
    Wang K; Zhang H; Li Y; Wei Q; Li H; Yang Y; Lu Y
    Transplant Proc; 2004 Sep; 36(7):2068-70. PubMed ID: 15518748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion from mycophenolate mofetil to azathioprine in high-risk renal allograft recipients on cyclosporine-based immunosuppression.
    Lou HX; Vathsala A
    Transplant Proc; 2004 Sep; 36(7):2090-1. PubMed ID: 15518756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil for prevention of liver allograft rejection: initial results of a controlled clinical trial.
    Sterneck M; Fischer L; Gahlemann C; Gundlach M; Rogiers X; Broelsch C
    Ann Transplant; 2000; 5(1):43-6. PubMed ID: 10850611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolate mofetil versus azathioprine in the maintenance therapy of lupus nephritis.
    Sahin GM; Sahin S; Kiziltas S; Masatlioglu S; Oguz F; Ergin H
    Ren Fail; 2008; 30(9):865-9. PubMed ID: 18925525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence.
    Pham PT; Pham PC
    Nephrol Dial Transplant; 2012 Jul; 27(7):2965-71. PubMed ID: 22207327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, prospective trial of mycophenolate mofetil versus azathioprine for prevention of acute renal allograft rejection after simultaneous kidney-pancreas transplantation.
    Merion RM; Henry ML; Melzer JS; Sollinger HW; Sutherland DE; Taylor RJ
    Transplantation; 2000 Jul; 70(1):105-11. PubMed ID: 10919583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil in multiple sclerosis.
    Frohman EM; Brannon K; Racke MK; Hawker K
    Clin Neuropharmacol; 2004; 27(2):80-3. PubMed ID: 15252268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azathioprine and interferon beta(1a) in relapsing-remitting multiple sclerosis patients: increasing efficacy of combined treatment.
    Lus G; Romano F; Scuotto A; Accardo C; Cotrufo R
    Eur Neurol; 2004; 51(1):15-20. PubMed ID: 14631124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Switching treatment between mycophenolate mofetil and azathioprine in lupus patients: indications and outcomes.
    Al Maimouni H; Gladman DD; Ibañez D; Urowitz MB
    Arthritis Care Res (Hoboken); 2014 Dec; 66(12):1905-9. PubMed ID: 24821661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of mycophenolate mofetil versus azathioprine after renal transplantation: a systematic review.
    Wang K; Zhang H; Li Y; Wei Q; Li H; Yang Y; Lu Y
    Transplant Proc; 2004 Sep; 36(7):2071-2. PubMed ID: 15518749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.